Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

Sellers EM, Toneatto T, Romach MK, Somer GR, Sobell LC, Sobell MB.

Alcohol Clin Exp Res. 1994 Aug;18(4):879-85.

PMID:
7978099
2.
3.

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.

Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID.

Psychopharmacology (Berl). 2001 Feb;154(1):23-7.

PMID:
11292002
4.

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.

Arch Gen Psychiatry. 2005 Jan;62(1):37-45.

PMID:
15630071
5.

A pilot double-blind treatment trial of memantine for alcohol dependence.

Evans SM, Levin FR, Brooks DJ, Garawi F.

Alcohol Clin Exp Res. 2007 May;31(5):775-82. Epub 2007 Mar 22.

PMID:
17378918
6.
7.

Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.

Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, Cowley DS, Ries RK.

J Clin Psychopharmacol. 2000 Apr;20(2):129-36.

PMID:
10770449
8.

Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group.

Cubeddu LX, Pendergrass K, Ryan T, York M, Burton G, Meshad M, Galvin D, Ciociola AA.

Am J Clin Oncol. 1994 Apr;17(2):137-46.

PMID:
8141105
9.

Fluoxetine attenuates alcohol intake and desire to drink.

Naranjo CA, Poulos CX, Bremner KE, Lanctot KL.

Int Clin Psychopharmacol. 1994 Sep;9(3):163-72.

PMID:
7814825
10.

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.

Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.

Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93.

PMID:
11093966
11.

Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.

Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J.

JAMA. 2000 Aug 23-30;284(8):963-71.

PMID:
10944641
12.

A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.

Kenna GA, Zywiak WH, McGeary JE, Leggio L, McGeary C, Wang S, Grenga A, Swift RM.

Alcohol Clin Exp Res. 2009 Feb;33(2):315-23. doi: 10.1111/j.1530-0277.2008.00835.x. Epub 2008 Nov 19.

PMID:
19032576
13.

A prospective, open-label trial of ondansetron in adolescents with alcohol dependence.

Dawes MA, Johnson BA, Ait-Daoud N, Ma JZ, Cornelius JR.

Addict Behav. 2005 Jul;30(6):1077-85. Epub 2004 Nov 10.

PMID:
15925118
14.

Effectiveness of naltrexone in a community treatment program.

Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF.

Alcohol Clin Exp Res. 2004 Nov;28(11):1710-7.

PMID:
15547458
16.

Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.

Müller C, Pongratz S, Pidlich J, Penner E, Kaider A, Schemper M, Raderer M, Scheithauer W, Ferenci P.

Eur J Gastroenterol Hepatol. 1998 Oct;10(10):865-70.

PMID:
9831410
17.

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.

Hong SJ, Ahn TH, Baek SH, Cho WH, Jeon HK, Kwan J, Yoon MH, Lee KJ, Lim DS.

Clin Ther. 2006 Apr;28(4):537-51. Erratum in: Clin Ther. 2006 Aug;28(8):1245. Jeon, Hyee-Kyoung [corrected to Jeon, Hui-Kyung]; Kyun, Jun [corrected to Kwan, Jun].

PMID:
16750465
18.

Efficacy of dexfenfluramine in the treatment of alcohol dependence.

Romach MK, Sellers EM, Kaplan HL, Somer GR, Gomez-Mancilla B.

Alcohol Clin Exp Res. 2000 Oct;24(10):1534-41.

PMID:
11045862
19.

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.

Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA.

Drug Alcohol Depend. 2006 Oct 1;84(3):256-63. Epub 2006 May 2.

PMID:
16631323

Supplemental Content

Support Center